BIOMETRY RESEARCH GROUP

Publications and Presentations

Bibliography -- 2000-2004

2004 | 2003 | 2002 | 2001 | 2000

2004

Andriole GL, Reding D, Hayes RB, Prorok PC, Gohagan JK, PLCO Steering Committee. The Prostate, Lung, Colon, and Ovarian (PLCO) Cancer Screening Trial: status and promise. Urology Oncology 2004;22(4):358-361.

Baker SG, Freedman LS. Correction: a simple method for analyzing data from a randomized trial with a missing binary outcome. BMC Medical Research Methodology 2004;4(1):1. (http://www.biomedcentral.com/1471-2288/4/1)

Baker SG, Kramer BS, Prorok PC. Comparing breast cancer mortality rates before-and-after a change in availability of screening in different regions: extension of the paired availability design. BMC Medical Research Methodology 2004(May 18);4(1):12.

Baker SG, Kramer BS, Prorok PC. Development tracks for cancer prevention markers. Dis Markers 2004;20(2):97-102.

Freedman LS, Fainberg V, Kipnis V, Midthune D, Carroll RJ. A new method for dealing with measurement error in explanatory variables of regression models. Biometrics 2004;60(1):172-181.

Gohagan J, Marcus P, Fagerstrom R, Pinsky P, Kramer B, Prorok P. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph. the Lung Screening Study of the National Cancer Institute. Chest 2004;126:114-112

Izmirlian G. Application of the random forest classification algorithm to a SELDI-TOF proteomics study in the setting of a cancer prevention trial. Ann NY Acad Sci 2004;1020:154-174.

Kapetanovic IM, Rosenfeld S, Izmirlian G. Overview of commonly used bioinformatics methods and their applications. Ann NY Acad Sci 2004;1020:10-21.

Rosenfeld S. A new method for testing normality based on properties of hermite orthogonal polynomials. Proceedings of the 2004 International Conference of Statistics, Mathematics and Related Fields, Waikiki, HI, June 9-12, 2004, pp. 739-755 (ISSN#1550-3747).

Rosenfeld S. Sampling from the bivariate gamma distribution with specified correlation coefficient and different marginal distributions. Proceedings of the 2004 International Conference of Statistics, Mathematics and Related Fields, Waikiki, HI, June 9-12, 2004, pp. 756-772 (ISSN#1550-3747).

Rosenfeld S. New develop ments in cancer-related computational statistics. Ann NY Acad Sci 2004;1020:22-31.

Rosenfeld S, Wang T, Kim Y, Milner J. Numerical deconvolution of cDNA microarray signal: simulation study. Ann NY Acad Sci 2004;1020:110-123.

Xiao Z, Luke BT, Izmirlian G, Umar A, Lynch PM, Phillips RK, Patterson S, Conrads TP, Veenstra TD, Greenwald P, Hawk ET, Ali IU. Serum proteomic profiles suggest celecoxib-modulated targets and response predictors. Cancer Res 2004;64(8):2904-2909.

Xu J-L, Fagerstrom RM, Prorok PC, Kramer BS. Estimating the cumulative risk of a false-positive test in a repeated screening program. Biometrics 2004;60:651-660.

2003

Baker SG. The central role of receiver operating characteristic (ROC) curves in evaluating tests for the early detection of cancer. J Natl Cancer Inst 2003;95(7):511-515.

Baker SG, Chia-Wen K, Graubard B. A sensitivity analysis for nonrandomly missing categorical data arising from a national health disability survey. Biostatistics 2003;1:41-56.

Baker SG, Erwin D, Kramer BS, Prorok PC. Using observational data to estimate an upper bound on the reduction in cancer mortality due to periodic screening. BMC Medical Research Methodology 2003(6 Mar);3:4. (http://www.biomedcentral.com/1471-2288/3/4)

Baker SG, Freedman LS. A simple method for analyzing data from a randomized trial with a missing binary outcome. BMC Medical Research Methodology 2003;3:8. (http://www.biomedcentral.com/1471-2288/3/8)

Baker SG, Kramer BS. Correction: the transitive fallacy for randomized trials: if A bests B and B bests C in separate trials, is A better than C? BMC Medical Research Methodology 2003;3:23. (http://www.biomedcentral.com/1471-2288/3/23)

Baker SG, Kramer BS. A perfect correlate does not a surrogate make. BMC Medical Research Methodology 2003;3:16. (http://www.biomedcentral.com/1471-2288/3/16)

Baker SG, Kramer BS. Randomized trials, generalizability, and meta-analysis: Graphical insights for binary outcomes. BMC Medical Research Methodology 2003(16 Jun);3:10. (http://www.biomedcentral.com/1471-2288/3/10)

Baker SG, Kramer BS. Estimating the cumulative risk of false positive cancer screenings. BMC Medical Research Methodology 2003(03 Jul ),3:11. (http://www.biomedcentral.com/1471-2288/3/11)

Berger VW, Bears J. When can a clinical trial be called 'randomized'? Vaccine 2003;21:468-472.

Berger VW, Ivanova A, Knoll MD. Minimizing predictability while retaining balance through the use of less restrictive randomization procedures. Statistics in Medicine 2003;22(19):3017-3028.

Berger VW, Rezvani A, Makarewicz V. Direct effect on validity of response run-in selection in clinical trials. Controlled Clinical Trials 2003;24(2):156-166.

Church TR (for the National Lung Screening Trial Executive Committee). Chest radiography as the comparison for spiral CT in the National Lung Screening Trial. Acad Radiol 2003;10:713-715.

Dorgan JF, Hunsberger SA, McMahon RP, Kwiterovich Jr. PO, Lauer RM, Van Horn L, Lasser NL, Stevens VJ, Friedman LA, Yanovski JA, Greenhut SF, Chandler DW, Franklin FA, Barton BA, Buckman DW, Snetselaar LG, Patterson BH, Schatzkin A, Taylor PR. Diet and sex hormones in girls: Findings from a randomized controlled clinical trial. J Natl Cancer Inst 2003;95(2):132-141.

Forman MR, Ballard-Barbash R, Kipnis V. Nutritional strategies for breast cancer prevention: what have we learned and where do we go from here? Cancer 2003;98(9):1782-1785.

Gohagan JK, Marcus PM, Fagerstrom RM, Black WC, Kramer BS, Pinsky PF, Prorok PC. Screening for lung cancer. In Williams C (ed). Evidence-Based Oncology. London:BMJ Books, 2003;164-171.

Kafadar K, Prorok PC. Alternative definitions of comparable case groups and estimates of lead time and benefit time in randomized cancer screening trials. Statistics in Medicine 2003;22:83-111.

Kipnis V, Subar AF, Midthune D, Freedman LS, Ballard-Barbash R, Troiano RP, Bingham S, Schoeller DA, Schatzkin A, Carroll RJ. Structure of dietary measurement error: Results of the OPEN Biomarker Study. American Journal of Epidemiology 2003;158(1):14-21.

Marcus PM. Conflicting evidence in lung cancer screening: Randomized controlled trials versus case-control studies. Lung Cancer 2003;41:37-39.

Michaud DS, Troiano RP, Subar AF, Runswick S, Bingham S, Kipnis V, Schatzkin A. Comparison of estimated renal net acid excretion from dietary intake and body size with urine pH. Journal of the American Dietetic Association 2003;103(8):1001-1007.

Ransohoff DF. Developing molecular biomarkers for cancer. Science 2003;299:1679-1680.

Schatzkin A, Kipnis V, Carroll RJ, Midthune D, Subar AF, Bingham S, Schoeller DA, Troiano RP, Freedman LS. A comparison of a food frequency questionnaire with a 24-hour recall for use in an epidemiological cohort study: results from the biomarker-based Observing Protein and Energy Nutrition (OPEN) study. International Journal of Epidemiology 2003;32(6):1054-1062.

Schoen RE, Pinsky PF, Weissfeld JL, Bresalier RS, Church T, Prorok P, Gohagan JK, for the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Group. Results of repeat sigmoidoscopy 3 years after a negative examination. JAMA 2003;290(1):41-48.

Subar AF, Kipnis V, Troiano RP, Midthune D, Schoeller DA, Bingham S, Sharbaugh CO, Trabulsi J, Runswick S, Ballard-Barbash R, Sunshine J, Schatzkin A. Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN study. American Journal of Epidemiology 2003;258(1):1-13.

Tangrea JA, Albert PS, Lanza E, Woodson K, Corle D, Hasson M, Burt R, Caan B, Paskett E, Iber F, Kikendall JW, Lance P, Shike M, Weissfeld J, Schatzkin A; Polyp Prevention Study Group. Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States). Cancer Causes Control 2003;14(5):403-411.

Trabulsi J, Troiano RP, Subar AF, Sharbaugh C, Kipnis V, Schatzkin A, Schoeller DA. Precision of the doubly labeled water method in a large-scale application: evaluation of a streamlined-dosing protocol in the Observing Protein and Energy Nutrition (OPEN) study. European Journal of Clinical Nutrition 2003;57(11):1370-1377.

Xu J-L, Prorok PC. Modelling and analysing exchangeable binary data with random cluster sizes. Statistics in Medicine 2003;22:2401-2416

2002

Baker SG, Kramer BS. The transitive fallacy for randomized trials: If A bests B and B bests C in separate trials, is A better than C? BMC Medical Research Methodology 2002(13 Nov);2(1):13. (http://www.biomedcentral.com/1471-2288/2/13)

Baker SG, Kramer BS, Prorok PC. Statistical issues in randomized trials of cancer screening. BMC Medical Research Methodology 2002 (19 Sept);2:11. (http://www.biomedcentral.com/1471-2288/2/11)

Baker SG, Kramer BS, Srivastava S. Markers for early detection of cancer: Statistical issues for nested case-control studies. BMC Medical Research Methodology 2002;2:4. (http://www.biomedcentral.com/1471-2288/2/4)

Baker SG, Tockman MS. Evaluating serial observations of precancerous lesions for further study as a trigger for early intervention. Statistics in Medicine 2002;21:2383-2390.

Berger VW. Improving the information content of categorical clinical trial endpoints. Controlled Clinical Trials 2002;23:502-514.

Berger VW, Ivanova A. Bias of linear rank tests for stochastic order in ordered categorical data. Journal of Statistical Planning and Inference 2002;107(1):237-247.

Berger VW, Ivanova A. Adaptive tests for ordinal data. Journal of Modern Applied Statistical Methods 2002;1(2):269-280.

Berger VW, Lunneborg C, Ernst MD, Levine JG. Parametric analyses in randomized clinical trials. Journal of Modern Applied Statistical Methods 2002:1(1):74-82.

Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BF. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst 2002;94:1537-1545.

de Koning HJ, Auvinen A, Sanchez AB, da Silva FC, Ciatto S, Denis L, Gohagan JK, Hakama M, Hugosson J, Kranse R, Nelen V, Prorok PC, Schröder FH for the ERSPC and the PLCO Trials: Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer Trial and the Prostate, Lung, Colorectal and Ovary Cancer Trial. Int J Cancer 2002;97:237-244.

Dorgan JF, Fears T, McMahon RP, Friedman LA, Patterson BH, Greenhut S. Measurement of steroid sex hormones in serum: a comparison of radioimmunoassay and mass spectrometry. Steroids 2002;67:151-158.

Engel LS, Taioli E, Pfeiffer R, Garcia-Closas M, Marcus PM, Lan Q, Boffetta P, Vineis P, Autrup H, Bell DA, Branch RA, Brockmoller J, Daly AK, Heckbert SR, Kalina I, Kang D, Katoh T, Lafuente A, Lin HJ, Romkes M, Taylor JA, Rothman N. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol 2002;156(2):95-109.

Kipnis V, Midthune D, Freedman L, Bingham S, Day NE, Riboli E, Ferrari P, Carroll RJ. Bias in dietary-report instruments and its implications for nutritional epidemiology. Public Health Nutrition 2002;5:915-923.

Marcus PM, Fagerstrom RM, Prorok PC, Gohagan JK, Kramer BS. Screening for lung cancer with helical CT scanning. Clinical Pulmonary Medicine 2002;9:323-329.

Marcus PM. Lung cancer screening, once again (letter). Chest 2002;122:3.

Marcus PM, Travis WD. Lung. In Franco EL, Rohan TE (eds). Cancer Precursors. New York, NY: Springer-Verlag, 2002:201-219.

Patterson BH, Dayton CM, Graubard BI. Latent class analysis of complex sample survey data: Application to dietary data. Journal of the American Statistical Society 2002;97:721-734.

Patterson BH, Dayton CM, Graubard BI. Rejoinder. Journal of the American Statistical Society 2002;738-741.

Potischman N, Coates RJ, Swanson CA, Carroll RJ, Daling JR, Brogan DR, Gammon MD, Midthune D, Curtin J, Brinton LA. Increased risk of early-stage breast cancer related to consumption of sweet foods among women less than age 45 in the United States. Cancer Causes Control 2002;13:937-946.

Shike M, Latkany L, Riedel E, Fleisher M, Schatzkin A, Lanza E, Corle D, Begg CB, the Polyp Prevention Trial Study Group. Lack of effect of a low-fat, high-fiber, -vegetable, and -fiber diet on serum prostate-specific antigen of men without prostate cancer: results from a randomized trial. Journal of Clinical Oncology 2002;20(17):3592-3598.

Stables GJ, Subar AF, Patterson BH, Dodd K, Heimendinger J, Van Duyn MA, Nebeling L. Changes in vegetable and fruit consumption and awareness among US adults. results of the 1991 and 1997 5 A Day for Better Health Program surveys. J Am Diet Assoc 2002;102(6):809-817.

Ransohoff DF. Challenges and opportunities in evaluating diagnostic tests. J Clin Epid 2002;55:1178-1182.

Thompson FE, Subar AF, Smith AF, Midthune D, Radimer KL, Kahle LL, Kipnis V. Fruit and vegetable assessment: Performance of 2 new short instruments and a food frequency questionnaire. J Am Diet Assoc 2002;102:1764-1772.

Thomson FE, Patterson BH, Weinstein SJ, McAdams M, Spate VL, Hamman RF, Levine RS, Mallin K, Stolley PD, Brinton LA, Morris JS, Ziegler RG. Serum selenium and the risk of cervical cancer among women in the United States. Cancer Causes and Controls 2002;13:517-526.

Weissfeld JL, Ling BS, Schoen RE, Bresalier RS, Riley T, Prorok PC. Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Cancer 2002;94:2569-2576.

2001

Baker SG. Evaluating periodic cancer screening without a randomized control group: a simplified design and analysis. In: Duffy SW, Hill C, Esteve J (eds). Quantitative Methods for the Evaluation of Cancer Screening. London: Edward Arnold Limited, 2001;34-41.

Baker SG, Lindeman KL. Rethinking historical controls. Biostatistics 2001,2:383-396.

Baker SG. Discussion of doubling sampling with survival analysis. Biometrics 2001;57:348-350.

Baker SG, Pinsky P. A proposed design and analysis for comparing digital and analog mammography: special ROC methods for cancer screening. Journal of the American Statistical Association 2001;96:421-428.

Baker SG, Kramer BS. Good for women, good for men, bad for people: Simpson's paradox and the importance of sex-specific analysis in observational studies. Journal of Women's Health & Gender-Based Medicine 2001;10:867- 872.

Baker SG, Lindeman KL, Kramer BS. The paired availability design for historical controls. BMC Medical Research Methodology 2001;1:9. (http://www.biomedcentral.com/1471-2288/1/9)

Berger VW, Ivanova A. Permutation tests for phase III clinical trials. In: Millard SP, Krause A (eds). Applied Statistics in the Pharmaceutical Industry with Case Studies Using S-PLUS. New York: Springer-Verlag, New York, 2001;349-374.

Berger VW. The p-value interval as an inferential tool. Journal of the Royal Statistical Society D 2001;50(1):79-85.

Block G, Mangels AR, Norkus EP, Patterson BH, Levander OA, Taylor PR. Ascorbic acid status and subsequent diastolic and systolic blood pressure. Hypertension 2001;37:261-267.

Corle DK, Sharbaugh C, Mateski DJ, Coyne T, Paskett ED, Cahill J, Daston C, Lanza E, Schatzkin A, the PPT Study Group. Self-rated quality of life measures: effect of change to a low-fat, high-fiber, fruit and vegetable enriched diet. Ann Behav Med 2001;23(3):198-207.

Frangakis C, Baker SG. Compliance adjusted double-sampling designs for comparative research: estimation and optimal planning. Biometrics 2001;57:899-908.

Gelmann EP, Chia D, Pinsky PF, Andriole GL, Crawford ED, Reding D, Hayes RB, Kramer BS, Woodrum DL, Gohagan JK, Levin DL. Relationship of demographic and clinical factors to free and total prostate-specific antigen. Urology 2001;58:561-566.

Honkanen V, Szalai JP, Siegel JN, Siegel A, Berger VW, Feldman BM. A three-phase clinical trial design for rare disorders. Statistics in Medicine 2001;20:3009-3021.

Ivanova A, Berger V. Drawbacks to integer scoring for ordered categorical data. Biometrics 2001;57:567-570.

Jiang WX, Kipnis V, Midthune D, Carroll RJ. Parameterization and inference for nonparametric regression problems. Journal of the Royal Statistical Society, Series B 2001;63(3):583-591.

Kipnis V, Midthune D, Freedman LS, Bingham S, Subar A, Schatzkin A, Carroll RJ. Empirical evidence of correlated biases in dietary assessment instruments and its implications. Am J Epidemiol 2001;153:394-403.

Lanza E, Schatzkin A, Daston C, Corle D, Freedman L, Ballard-Barbash R, Caan B, Lance P, Marshall J, Iber F, Shike M, Weissfeld J, Slattery M, Paskett E, Mateski D, the PPT Study Group. Implementation of a 4-year high fiber, high fruit/vegetable, low fat dietary intervention: results of dietary change in the Polyp Prevention Trial. Am J Clin Nutr 2001;74(3):387-401.

Marcus PM. Lung cancer screening: an update. J Clin Oncol 2001;19S:83S-86S.

McShane LM, Midthune DN, Dorgan JF, Freedman LS, Carroll RJ. Covariate measurement error adjustment for matched case-control studies. Biometrics 2001;57:62-73.

Melzer D, Izmirlian G, Leveille SG, Guralnik JM. Educational differences in the prevalence of mobility disability in old age: the dynamics of incidence, mortality, and recovery. Journal of Gerontology: SOCIAL SCIENCES 2001;56B(5):S294-S301.

Potosky AL, Feuer EJ, Levin DL. Impact of screening on incidence and mortality of prostate cancer in the United States. Epidemiol Rev 2001;23(1):181-186.

Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, Hurwitz PE, Coyle L, Schussler N, Michaud DS, Freedman LS, Brown CC, Midthune D, Kipnis V. Design and serendipity in establishing a large cohort with wide dietary intake distributions - the National Institutes of Health-American Association of Retired Persions Diet and Health Study. Am J Epidemiol 2001;154(12):1119-1125.

Spiegelman D, Carroll R, Kipnis V. Efficient regression calibration for logistic regression for main study/internal validation study designs with an imperfect reference instrument. Stat Med 2001;20:139-160. Baker SG, Lindeman, KS. Randomized and nonrandomized studies. statistical considerations (editorial). Anesthesiology 2000;92:928-930.

Subar AF, Thompson FE, Kipnis V, Midthune D, Hurwitz P, McNutt S, McIntosh A, Rosenfeld S. Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: the Eating at America's Table Study. Am J Epidemiol 2001;154(12):1089-1099.

2000

Baker SG, Lindeman KS. Randomized and nonrandomized studies. Statistical considerations (editorial). Anesthesiology 2000;92:928-30.

Baker SG. Analyzing a randomized cancer prevention trial with a missing binary outcome, an auxiliary variable, and all-or-none compliance. J Am Stat Assoc 2000;95:43-50.

Baker SG. Identifying combinations of cancer biomarkers for further study as triggers of early intervention. Biometrics 2000;56:1082-1087.

Berger VW. Critique of Ludbrook and Dudley. American Statistician 2000;54(1):85-86.

Berger VW. Pros and cons of permutation tests. Stat Med 2000;19:1319-1328.

Buyske S, Fagerstrom R, Ying Z. A class of weighted log-rank tests for survival data when the event is rare. J Am Stat Assoc 2000;95:249-258.

Connor RJ, Boer R, Prorok PC, Weed DL. Investigation of design and bias issues in case-control studies of cancer screening using microsimulation. Am J Epidemiol 2000;151(10):991-998.

Gohagan JK, Levin DL, Prorok PC, Sullivan D (eds). The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21(6 Suppl):249S-406S.

Gohagan JK, Prorok PC, Hayes R, Kramer BS. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials 2000;21(6 Suppl):251S-272S.

Hartge P, Hayes R, Reding D, Sherman ME, Prorok P, Schiffman M, Buys S. Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the Prostate, Lung, Colon, and Ovarian Cancer Screening Trial. Am J Obstet Gynecol 2000;183(5):1232-1237.

Hasson MA, Fagerstrom RM, Kahane DC, Walsh JH, Myers MH, Caughman C, Wenzel B, Haralson JC, Flickinger LM, Turner LM. Design and evolution of the data management systems in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21(6 Suppl):329S-348S.

Havlik RJ, Izmirlian G, Petrovitch H, Ross GW, Masaki K, Curb JD, Saunders AM, Foley DJ, Brock DB, Launer LJ, White L. APOE-epsilon4 predicts incident AD in Japanese-American men: the Honolulu-Asia Aging Study. Neurology 2000;54;1526-1529.

Izmirlian G, Brock DB, Ferrucci L, Phillips C. Active life expectancy from annual follow-up data with missing responses. Biometrics 2000;56(1):244-248

Izmirlian G, Brock DB, White L. Estimating incidence of dementia sub-types: assessing the impact of missed cases. Stat Med 2000;19:1577-1591.

Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with application to cancer rates. Stat Med 2000;19:335-351.

Kipnis V, Carroll RJ, Freedman LS, Li L. Re: "Implications of a new dietary measurement error model for estimation of relative risk: application to four calibration studies" The authors reply (letter). Am J Epidemiol 2000;152:495-496.

Kulldorff M, McShane LM, Schatzkin A, Freedman LS, Wargovich MJ, Woods C, Purewal M, Burt RW, Lawson M, Mateski DJ, Lanza E, Corle DK, O'Brien B, Moler J. Measuring cell proliferation in the rectal mucosa. comparing bromodeoxyuridine (BrdU) and proliferating cell nuclear antigen (PCNA) assays. J Clin Epidemiol 2000;53(8):875-883.

Leveille SG, Pennix BW, Melzer D, Izmirlian G, Guralnik JM. Sex differences in the prevalence of mobility misability in old age: the dynamics of incidence, recovery and mortality. J Gerontol B Psychol Sci Soc Sci 2000;55(1):S41-S50.

Marcus PM, Bergstralh EJ, Fagerstrom RM, Williams DE, Fontana R, Taylor WF, Prorok PC. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst 2000;92:1308-1316.

Marcus PM, Hayes RB, Vineis P, Garcia-Closas M, Caporaso NE, Autrup H, Branch RA, Brockmoller J, Ishizaki T, Karakaya AE, Ladero JM, Mommsen S, Okkels H, Romkes M, Roots I, Rothman N. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol Biomarkers Prev 2000;9(5):461-467.

Marcus PM, Newman B, Millikan RC, Moorman PG, Baird DD, Qaqish B. The association of adolescent cigarette smoking, alcoholic beverage consumption, environmental tobacco smoke, and ionizing radiation with subsequent breast cancer risk. Cancer Causes Control 2000;11:271-278.

Marcus PM, Vineis P, Rothman N. NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 studies. Pharmacogenetics 2000;10:115-122.

Marcus PM. Television as a venue for cancer education: the General Hospital experience. J Cancer Educ 2000;15:4.

Masaki K, Losonsczy KG, Izmirlian G, Foley DJ, Ross GW, Petrovitch H, Havlik RJ, White L. Association of vitamin E and C supplement use with cognitive function and dementia in elderly Japanese-American men: the Honolulu-Asia Aging Study. Neurology 2000;54(6):1265-1272

Masaki KH, White LR, Foley DJ, Petrovitch H, Izmirlian G, Havlik R, Ross GW, Losonczy KG. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men - Reply. Neurology 2000;55(6):901-902.

O'Brien B, Nichaman L, Browne JEH, Levin DL, Prorok PC, Gohagan JK. Coordination and management of a large multicenter screening trial: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21(6 Suppl):310S-328S.

Permutt T, Berger VW. Rank tests in ordered 2xk contingency tables. Communications in Statistics, Theory and Methods 2000;29(5):989-1003.

Petrovitch H, White LR, Izmirilian G, Ross GW, Havlik RJ, Markesbery W, Nelson J, Davis DG, Hardman J, Foley DJ, Launer LJ. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Neurobiol Aging 2000;21:57-62

Prorok PC, Andriole GL, Bresalier R, Buys S, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes R, Johnson CC, Mandel JS, O'Brien B, Oken M, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21(6 Suppl):273S-309S.

Rosenfeld S, Grody N. Metamorphic signature of snow revealed in SSM/I measurements. IEEE Transactions on Geoscience and Remote Sensing 2000;38(1):53-63.

Schatzkin A, Lanza E, Corle D, Lance P, Iber F, Caan B, Shike M, Weissfeld J, Burt R, Cooper MR, Kikendall JW, Cahill J, the Polyp Prevention Trial Study Group. Lack of effect of a low-fat, high-fiber, fruit- and vegetable-enriched diet on the recurrence of colorectal adenomas. N Engl J Med 2000;342(16):1149-1155.

Stein, M, Rich J, Maksad J, Chen MH, Hu P, Sobota M, Clark J. Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use. Am J Drug Alcohol Abuse 2000;26(2):195-205.

Subar AF, Midthune D, Kulldorff M, Brown CC, Thompson FE, Kipnis V, Schatzkin A. Evaluation of alternative approaches to assign nutrient values to food groups in food frequency questionnaires. Am J Epidemiol 2000;152:279-286.

Thompson FE, Kipnis V, Subar AF, Krebs-Smith SM, Kahle LL, Midthune D, Potischman N, Schatzkin A. Evaluation of 2 brief instruments and a food-frequency questionnaire to estimate daily number of servings of fruit and vegetables. Am J Clin Nutr 2000;71:1503-1510.

Weissfeld JL, Fagerstrom RM, O'Brien B. Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21(6 Suppl):390S-399S.